Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.
Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.
复制标题
DOI:
10.3389/fimmu.2022.844271
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
Zeng D
中科院分区:
文献类型:
--
作者:
Song Q;Nasri U;Zeng D
Intestinal graft-versus-host disease (Gut-GVHD) is one of the major causes of mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). While systemic glucocorticoids (GCs) comprise the first-line treatment option, the response rate for GCs varies from 30% to 50%. The prognosis for patients with steroid-refractory acute Gut-GVHD (SR-Gut-aGVHD) remains dismal. The mechanisms underlying steroid resistance are unclear, and apart from ruxolitinib, there are no approved treatments for SR-Gut-aGVHD. In this review, we provide an overview of the current biological understanding of experimental SR-Gut-aGVHD pathogenesis, the advanced technology that can be applied to the human SR-Gut-aGVHD studies, and the potential novel therapeutic options for patients with SR-Gut-aGVHD.
登录
查看更多内容
影响因子:
9.1
作者:
Cao, Jiang;Chen, Chong;Xu, Kai-lin
通讯作者:
Xu, Kai-lin
影响因子:
32.4
作者:
Basu R;O'Quinn DB;Silberger DJ;Schoeb TR;Fouser L;Ouyang W;Hatton RD;Weaver CT
通讯作者:
Weaver CT
DOI:
10.21926/obm.transplant.1901044
发表时间:
2019
期刊:
OBM transplantation
影响因子:
--
作者:
Hamers AAJ;Joshi SK;Pillai AB
通讯作者:
Pillai AB
影响因子:
5.4
作者:
Chen, X;Murakami, T;Howard, DMZ
通讯作者:
Howard, DMZ
DOI:
10.1186/1476-7961-11-1
发表时间:
2013-01-25
期刊:
Clinical and molecular allergy : CMA
影响因子:
--
作者:
Singh AM;Dahlberg P;Burmeister K;Evans MD;Gangnon R;Roberg KA;Tisler C;Dasilva D;Pappas T;Salazar L;Lemanske RF Jr;Gern JE;Seroogy CM
通讯作者:
Seroogy CM